X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
index medicus (12) 12
hematology (8) 8
male (8) 8
aged (7) 7
female (7) 7
middle aged (7) 7
adult (6) 6
lymphomas (6) 6
stem cells (6) 6
chemotherapy (5) 5
treatment outcome (5) 5
aged, 80 and over (4) 4
anthracyclines (4) 4
care and treatment (4) 4
transplantation (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
disease (3) 3
doxorubicin (3) 3
non-hodgkins-lymphoma (3) 3
oncology (3) 3
rituximab (3) 3
survival analysis (3) 3
adolescent (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
cancer (2) 2
cyclophosphamide (2) 2
diseases (2) 2
dose-response relationship, drug (2) 2
doxorubicin - administration & dosage (2) 2
follow-up studies (2) 2
hemic and lymphatic diseases (2) 2
hodgkin disease - drug therapy (2) 2
hodgkin disease - pathology (2) 2
hodgkin lymphoma (2) 2
hodgkin's lymphoma (2) 2
lymphoma, b-cell - drug therapy (2) 2
lymphoma, t-cell - drug therapy (2) 2
non-hodgkin's lymphomas (2) 2
patients (2) 2
phase-ii (2) 2
prognosis (2) 2
radioimmunotherapy (2) 2
relapse (2) 2
survival (2) 2
toxicity (2) 2
young adult (2) 2
131 i (1) 1
2 nitrosoureas (1) 1
abvd (1) 1
activation (1) 1
acute lymphoblastic-leukemia (1) 1
adults (1) 1
aged patients (1) 1
aggressive lymphoma (1) 1
algorithm (1) 1
alkyltransferase (1) 1
american-college (1) 1
anemia, dyserythropoietic, congenital - complications (1) 1
animals (1) 1
ankle - blood supply (1) 1
anthracycline-induced cardiotoxicity (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antibodies (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, murine-derived (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
antikörper (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, alkylating (1) 1
antineoplastic agents, alkylating - adverse effects (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
association task-force (1) 1
at-hook (1) 1
autoregulation (1) 1
b-lymphocytes - pathology (1) 1
bcl-2-associated x protein - metabolism (1) 1
beacopp (1) 1
bioindicators (1) 1
biomarkers (1) 1
biomarkers, tumor - blood (1) 1
bleomycin (1) 1
bleomycin - administration & dosage (1) 1
bleomycin - adverse effects (1) 1
bleomycin - therapeutic use (1) 1
blutgefässe (1) 1
bortezomib (1) 1
burkitt lymphoma (1) 1
burkitt lymphoma - drug therapy (1) 1
burkitt lymphoma - pathology (1) 1
burkitt's lymphoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2009, Volume 64, Issue 5, pp. 907 - 916
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2012, Volume 156, Issue 2, pp. 234 - 244
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 05/2014, Volume 41, Issue 5, p. 867
  The extra-domain A1 of tenascin-C (TC-A1) is highly expressed in the extracellular matrix of tumours and on newly formed blood vessels and is thus a valuable... 
Immunotherapy | Monoclonal antibodies | Lymphomas | Patients | Radioactivity
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 05/2014, Volume 41, Issue 5, pp. 867 - 877
Purpose: The extra-domain A1 of tenascin-C (TC-A1) is highly expressed in the extracellular matrix of tumours and on newly formed blood vessels and is thus a... 
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 05/2014, Volume 41, Issue 5, p. 867
The extra-domain A1 of tenascin-C (TC-A1) is highly expressed in the extracellular matrix of tumours and on newly formed blood vessels and is thus a valuable... 
Viral antibodies | Care and treatment | Chemotherapy | Nuclear radiation | Radioimmunotherapy | Stem cells | Antibodies | Development and progression | Lymphomas | Cancer
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2011, Volume 154, Issue 5, pp. 579 - 589
This Phase II study assessed feasibility and efficacy of a biweekly R‐COMP‐14 regimen (rituximab, cyclophosphamide, non‐pegylated liposome‐encapsulated... 
non‐pegylated liposomal doxorubicin | cardiotoxicity | diffuse large B‐cell lymphoma | Charlson Comorbidity Index | elderly | Cardiotoxicity | Elderly | Non-pegylated liposomal doxorubicin | Diffuse large B-cell lymphoma | GUIDELINE UPDATE | AMERICAN-COLLEGE | diffuse large B-cell lymphoma | non-pegylated liposomal doxorubicin | CARDIAC-DISEASES | LEFT-VENTRICULAR DYSFUNCTION | OLDER PATIENTS | SEPTIC SHOCK | NON-HODGKINS-LYMPHOMA | ANTHRACYCLINE-INDUCED CARDIOTOXICITY | ASSOCIATION TASK-FORCE | AGGRESSIVE LYMPHOMA | HEMATOLOGY | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Comorbidity | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Rituximab | Lymphoma, Large B-Cell, Diffuse - complications | Male | Risk | Treatment Outcome | Polyethylene Glycols - administration & dosage | Heart Diseases - epidemiology | Doxorubicin - analogs & derivatives | Survival Analysis | Aged, 80 and over | Vincristine - administration & dosage | Female | Aged | Heart Diseases - drug therapy | Doxorubicin - administration & dosage | Anthracyclines | Cyclophosphamide | Corticosteroids | Stem cells | Aged patients | Transplantation | Lymphomas | Prednisone | Steroids | Index Medicus | Haematological Malignancy
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 37, pp. 59158 - 59172
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2014, Volume 166, Issue 1, pp. 118 - 129
Journal Article
Haematologica, ISSN 0390-6078, 03/2005, Volume 90, Issue 3, pp. ECR14 - ECR14
Hematology-Oncology Unit, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Via Mariano Semmola, I-80131, Naples, Italy. We report the results of... 
Splenic Neoplasms - drug therapy | Lymphoma, T-Cell - drug therapy | Pentostatin - therapeutic use | Humans | Liver Neoplasms - drug therapy | Receptors, Antigen, T-Cell, gamma-delta | Antineoplastic Agents - therapeutic use | Index Medicus
Journal Article